Lyfe Capital, a Chinese healthcare-focused private equity firm, has closed its debut fund at US$298 million to make early-stage equity investments in the the pharmaceuticals, medical device, digital healthcare, diagnostics sectors in China, according to a company announcement. The fund is made of two vehicles, a US$210 million U.S. dollar fund and a RMB555 million […]<\/p>\n
Visit ChinaMoneyNetwork.com<\/b><\/a> for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod<\/a> subscribe to all episodes on iTunes<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":" Lyfe Capital, a Chinese healthcare-focused private equity firm, has closed its debut fund at US$298 million to make early-stage equity investments in the the pharmaceuticals, medical device, digital healthcare, diagnostics sectors in China, according to a company announcement. The fund is made of two vehicles, a US$210 million U.S. dollar fund and a RMB555 million […]<\/p>\n Visit ChinaMoneyNetwork.com<\/b><\/a> for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod<\/a> subscribe to all episodes on iTunes<\/a>.<\/p>\n","protected":false},"author":146,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[194,1623],"tags":[7198,7593,4502,8101],"class_list":["post-30922","post","type-post","status-publish","format-standard","hentry","category-news-chinese-law","category-venture-capital","tag-bio-pharma","tag-fund-news","tag-fundraising","tag-healthcare-fund"],"_links":{"self":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/30922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/users\/146"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/comments?post=30922"}],"version-history":[{"count":1,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/30922\/revisions"}],"predecessor-version":[{"id":30924,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/posts\/30922\/revisions\/30924"}],"wp:attachment":[{"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/media?parent=30922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/categories?post=30922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chinalegalblog.com\/en\/wp-json\/wp\/v2\/tags?post=30922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}